Cargando…

Human gastric cancer modelling using organoids

OBJECTIVE: Gastric cancer is the second leading cause of cancer-related deaths and the fifth most common malignancy worldwide. In this study, human and mouse gastric cancer organoids were generated to model the disease and perform drug testing to delineate treatment strategies. DESIGN: Human gastric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seidlitz, Therese, Merker, Sebastian R, Rothe, Alexander, Zakrzewski, Falk, von Neubeck, Cläre, Grützmann, Konrad, Sommer, Ulrich, Schweitzer, Christine, Schölch, Sebastian, Uhlemann, Heike, Gaebler, Anne-Marlene, Werner, Kristin, Krause, Mechthild, Baretton, Gustavo B, Welsch, Thilo, Koo, Bon-Kyoung, Aust, Daniela E, Klink, Barbara, Weitz, Jürgen, Stange, Daniel E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Stomach
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352409/ https://www.ncbi.nlm.nih.gov/pubmed/29703791 http://dx.doi.org/10.1136/gutjnl-2017-314549

Ejemplares similares

Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations
por: Seidlitz, Therese, et al.
Publicado: (2019)

CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype
por: Barros, Rita, et al.
Publicado: (2010)

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
por: Deng, Niantao, et al.
Publicado: (2012)

Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers
por: Laine, Loren, et al.
Publicado: (2012)

Prescription of and Adherence to Non-Steroidal Anti-Inflammatory Drugs and Gastroprotective Agents in At-Risk Gastrointestinal Patients
por: Lanas, Angel, et al.
Publicado: (2012)

Competing Influences in the Management of Gastrointestinal Bleeding
por: Sonnenberg, Amnon
Publicado: (2012)

A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori
por: Basu, P Patrick, et al.
Publicado: (2011)

GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial
por: Cryer, Byron, et al.
Publicado: (2013)

Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding
por: Scholtz, Samantha, et al.
Publicado: (2014)

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
por: Filion, Kristian B, et al.
Publicado: (2014)

HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer
por: Chang, Hae Ryung, et al.
Publicado: (2016)

Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study
por: Asada, Kiyoshi, et al.
Publicado: (2015)

OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer
por: Qian, Jin, et al.
Publicado: (2015)

Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas
por: Lin, Suling J, et al.
Publicado: (2015)

Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
por: Fang, Yu-Jen, et al.
Publicado: (2015)

POU2F2-oriented network promotes human gastric cancer metastasis
por: Wang, Si-Meng, et al.
Publicado: (2016)

MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome
por: Wang, Kunning, et al.
Publicado: (2016)

Impairment of Salivary Mucin Production Resulting in Declined Salivary Viscosity During Naproxen Administration as a Potential Link to Upper Alimentary Tract Mucosal Injury
por: Garcia, Cesar J, et al.
Publicado: (2013)

Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
por: Wang, Ting-ting, et al.
Publicado: (2017)

Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
por: Ferreira, Rui M, et al.
Publicado: (2018)

Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD)
por: Taylor, Fiona, et al.
Publicado: (2018)

Mucosal microbiome dysbiosis in gastric carcinogenesis
por: Coker, Olabisi Oluwabukola, et al.
Publicado: (2018)

Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study
por: Cai, Quancai, et al.
Publicado: (2019)

Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection
por: Boccellato, Francesco, et al.
Publicado: (2019)

Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies
por: Wang, Zhaoming, et al.
Publicado: (2017)

Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication
por: Sung, Joseph J Y, et al.
Publicado: (2020)

Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles
por: Erawijantari, Pande Putu, et al.
Publicado: (2020)

MiR130b from Schlafen4(+) MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer
por: Ding, Lin, et al.
Publicado: (2020)

Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach
por: Bockerstett, Kevin A, et al.
Publicado: (2020)

DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia
por: Krishnan, Vaidehi, et al.
Publicado: (2020)

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response
por: Wang, Ruiping, et al.
Publicado: (2020)

Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis
por: Wang, Pin, et al.
Publicado: (2019)

MicroRNA-92a-1–5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia
por: Li, Ting, et al.
Publicado: (2019)

Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing
por: Zhang, Min, et al.
Publicado: (2021)

Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population
por: So, Jimmy Bok Yan, et al.
Publicado: (2021)

Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands
por: Chiang, Tsung-Hsien, et al.
Publicado: (2021)

Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom
por: Ye, Yizhou, et al.
Publicado: (2021)

Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination
por: Sundar, Raghav, et al.
Publicado: (2021)

Iqgap3-Ras axis drives stem cell proliferation in the stomach corpus during homoeostasis and repair
por: Matsuo, Junichi, et al.
Publicado: (2021)

Chief cell plasticity is the origin of metaplasia following acute injury in the stomach mucosa
por: Caldwell, Brianna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6479p1ublqrq6tgimvn9qam4ne